Interleukin-33 and inflammatory bowel diseases: Lessons from human studies

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Nunes, Tiago ^a   Bernardazzi, Claudio ^b   De Souza, Heitor S ^b,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 33; MESSENGER RNA; CYTOKINE; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

BIOPSY; CANCER SCREENING; COLON BIOPSY; COLON CANCER; CROHN DISEASE; DISEASE ACTIVITY; DIVERTICULITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM CELL; INTESTINE INFECTION; INTESTINE MUCOSA; LAMINA PROPRIA; LYMPHOCYTE; MACROPHAGE; MYOFIBROBLAST; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL; ULCERATIVE COLITIS; UPREGULATION; ANIMAL; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; INTESTINE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKINS; INTESTINAL MUCOSA; INTESTINES; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 84896261917     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/423957     Document Type: Review

References (54)

1. Fiocchi C., Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998 115 1 182 205 2-s2.0-0031781603 10.1016/S0016-5085(98) 70381-6 (Pubitemid 28307304)
2. Scaldaferri F., Fiocchi C., Inflammatory bowel disease: progress and current concepts of etiopathogenesis. Journal of Digestive Diseases 2007 8 4 171 178 2-s2.0-38449113183 10.1111/j.1751-2980.2007.00310.x
3. Nunes T., Fiorino G., Danese S., Sans M., Familial aggregation in inflammatory bowel disease: is it genes or environment? World Journal of Gastroenterology 2011 17 22 2715 2722 2-s2.0-79959525963 10.3748/wjg.v17.i22. 2715
4. Khor B., Gardet A., Xavier R. J., Genetics and pathogenesis of inflammatory bowel disease. Nature 2011 474 7351 307 317 2-s2.0-79959216005 10.1038/nature10209
5. Pastorelli L., de Salvo C., Vecchi M., Pizarro T. T., The role of IL-33 in gut mucosal inflammation. Mediators of Inflammation 2013 2013 11 608187 10.1155/2013/608187
6. Daniel C., Sartory N. A., Zahn N., Radeke H. H., Stein J. M., Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Journal of Pharmacology and Experimental Therapeutics 2008 324 1 23 33 2-s2.0-37349104972 10.1124/jpet.107.127209 (Pubitemid 350294165)
7. Cobrin G. M., Abreu M. T., Defects in mucosal immunity leading to Crohn's disease. Immunological Reviews 2005 206 277 295 2-s2.0-23344431535 10.1111/j.0105-2896.2005.00293.x (Pubitemid 41105176)
8. Targan S. R., Karp L. C., Defects in mucosal immunity leading to ulcerative colitis. Immunological Reviews 2005 206 296 305 2-s2.0-23344446340 10.1111/j.0105-2896.2005.00286.x (Pubitemid 41105177)
9. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., Fujiyama Y., Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003 52 1 65 70 2-s2.0-0037216498 10.1136/gut.52.1.65 (Pubitemid 36020767)
10. Weaver C. T., Harrington L. E., Mangan P. R., Gavrieli M., Murphy K. M., Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006 24 6 677 688 2-s2.0-33744984785 10.1016/j.immuni.2006.06.002 (Pubitemid 43867371)
11. Iwakura Y., Ishigame H., The IL-23/IL-17 axis in inflammation. Journal of Clinical Investigation 2006 116 5 1218 1222 2-s2.0-33646417072 10.1172/JCI28508
12. Steinman L., A brief history of TH17, the first major revision in the T H1/TH2 hypothesis of T cell-mediated tissue damage. Nature Medicine 2007 13 2 139 145 2-s2.0-33846966636 10.1038/nm1551
13. Waite J. C., Skokos D., Th17 response and inflammatory autoimmune diseases. International Journal of Inflammation 2012 2012 10 819467 10.1155/2012/819467
14. Salas A., The IL-3/ST2 axis: yet another therapeutic target in inflammatory bowel disease? Gut 2013 62 10 1392 1393 10.1136/gutjnl-2012-303920
15. Kobori A., Yagi Y., Imaeda H., Ban H., Bamba S., Tsujikawa T., Saito Y., Fujiyama Y., Andoh A., Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. Journal of Gastroenterology 2010 45 10 999 1007 2-s2.0-78249249625 10.1007/s00535-010-0245-1
16. Pastorelli L., Garg R. R., Hoang S. B., Spina L., Mattioli B., Scarpa M., Fiocchi C., Vecchi M., Pizarro T. T., Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proceedings of the National Academy of Sciences of the United States of America 2010 107 17 8017 8022 2-s2.0-77952324145 10.1073/pnas.0912678107
17. Seidelin J. B., Bjerrum J. T., Coskun M., Widjaya B., Vainer B., Nielsen O. H., IL-33 is upregulated in colonocytes of ulcerative colitis. Immunology Letters 2010 128 1 80 85 2-s2.0-74649085973 10.1016/j.imlet.2009.11.001
18. Beltrán C. J., Núñez L. E., Díaz- Jiménez D., Farfan N., Candia E., Heine C., López F., González M. J., Quera R., Hermoso M. A., Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2010 16 7 1097 1107 2-s2.0-77953721901 10.1002/ibd.21175
19. Sponheim J., Pollheimer J., Olsen T., Balogh J., Hammarström C., Loos T., Kasprzycka M., Sørensen D. R., Nilsen H. R., Küchler A. M., Vatn M. H., Haraldsen G., Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. American Journal of Pathology 2010 177 6 2804 2815 2-s2.0-78650199530 10.2353/ajpath.2010.100378
20. Sedhom M. A., Pichery M., Murdoch J. R., Foligné B., Ortega N., Normand S., Mertz K., Sanmugalingam D., Brault L., Grandjean T., Lefrancais E., Fallon P. G., Quesniaux V., Peyrin-Biroulet L., Cathomas G., Junt T., Chamaillard M., Girard J. P., Ryffel B., Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut 2012 62 12 1714 1723 10.1136/gutjnl-2011-301785. E
21. Wakahara K., Baba N., Van V. Q., Bégin P., Rubio M., Ferraro P., Panzini B., Wassef R., Lahaie R., Caussignac Y., Tamaz R., Richard C., Soucy G., Delespesse G., Sarfati M., Human basophils interact with memory T cells to augment Th17 responses. Blood 2012 120 24 4761 4771 10.1182/blood-2012-04-424226
22. Ajduković J., Tonkić A., Salamunić I., Hozo I., Šimunić M., Bonacin D., Interleukins IL-33 and IL-17/IL-17A in patients with ulcerative colitis. Hepato-Gastroenterology 2010 57 104 1442 1444 2-s2.0-79952435375
23. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T. K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D. M., Bazan J. F., Kastelein R. A., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005 23 5 479 490 2-s2.0-27744446058 10.1016/j.immuni.2005.09.015 (Pubitemid 41587888)
24. Moussion C., Ortega N., Girard J., The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel "Alarmin"? PLoS ONE 2008 3 10 2-s2.0-53749093767 10.1371/journal.pone.0003331 e3331
25. Baekkevold E. S., Roussigné M., Yamanaka T., Johansen F., Jahnsen F. L., Amalric F., Brandtzaeg P., Erard M., Haraldsen G., Girard J., Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. American Journal of Pathology 2003 163 1 69 79 2-s2.0-0037631696 (Pubitemid 36759592)
26. Pastorelli L., de Salvo C., Cominelli M. A., Vecchi M., Pizarro T. T., Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation. Therapeutic Advances in Gastroenterology 2011 4 5 311 323 2-s2.0-80052370458 10.1177/1756283X11410770
27. Wood I. S., Wang B., Trayhurn P., IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochemical and Biophysical Research Communications 2009 384 1 105 109 2-s2.0-65549163320 10.1016/j.bbrc.2009.04.081
28. Cayrol C., Girard J., The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proceedings of the National Academy of Sciences of the United States of America 2009 106 22 9021 9026 2-s2.0-67049158193 10.1073/pnas.0812690106
29. Lingel A., Weiss T. M., Niebuhr M., Pan B., Appleton B. A., Wiesmann C., Bazan J. F., Fairbrother W. J., Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 2009 17 10 1398 1410 2-s2.0-70349759672 10.1016/j.str.2009.08.009
30. Lüthi A. U., Cullen S. P., McNeela E. A., Duriez P. J., Afonina I. S., Sheridan C., Brumatti G., Taylor R. C., Kersse K., Vandenabeele P., Lavelle E. C., Martin S. J., Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009 31 1 84 98 2-s2.0-68249137289 10.1016/j.immuni.2009.05.007
31. Talabot-Ayer D., Lamacchia C., Gabay C., Palmer G., Interleukin-33 is biologically active independently of caspase-1 cleavage. The Journal of Biological Chemistry 2009 284 29 19420 19426 2-s2.0-67651053209 10.1074/jbc.M901744200
32. Lefrancais E., Roga S., Gautier V., Gonzalez-de-Peredo A., Monsarrat B., Girard J.-P., Cayrol C., IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proceedings of the National Academy of Sciences of the United States of America 2012 109 5 1673 1678 10.1073/pnas.1115884109
33. Hong J., Bae S., Jhun H., Lee S., Choi J., Kang T., Kwak A., Hong K., Kim E., Jo S., Kim S., Identification of constitutively active interleukin 33 (IL-33) splice variant. The Journal of Biological Chemistry 2011 286 22 20078 20086 2-s2.0-79957595391 10.1074/jbc.M111.219089
34. Boraschi D., Tagliabue A., The interleukin-1 receptor family. Vitamins and Hormones 2006 74 229 254 2-s2.0-33947727646 10.1016/S0083-6729(06)74009-2
35. Dinarello C. A., An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity 2005 23 5 461 462 2-s2.0-27744438007 10.1016/j.immuni.2005.10.004 (Pubitemid 41587885)
36. Bergers G., Reikerstorfer A., Braselmann S., Graninger P., Busslinger M., Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. The EMBO Journal 1994 13 5 1176 1188 2-s2.0-0028204189 (Pubitemid 24074724)
37. Klemenz R., Hoffmann S., Werenskiold A.-K., Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proceedings of the National Academy of Sciences of the United States of America 1989 86 15 5708 5712 2-s2.0-0008519249 (Pubitemid 19217524)
38. Tominaga S., A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Letters 1989 258 2 301 304 2-s2.0-0024404517 10.1016/0014- 5793(89)81679-5 (Pubitemid 20001074)
39. Löhning M., Stroehmann A., Coyle A. J., Grogan J. L., Lin S., Gutierrez-Ramos J., Levinson D., Radbruch A., Kamradt T., T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proceedings of the National Academy of Sciences of the United States of America 1998 95 12 6930 6935 2-s2.0-0032499678 10.1073/pnas.95.12.6930 (Pubitemid 28278084)
40. Trajkovic V., Sweet M. J., Xu D., T1/ST2-An IL-1 receptor-like modulator of immune responses. Cytokine and Growth Factor Reviews 2004 15 2-3 87 95 2-s2.0-1942535018 10.1016/j.cytogfr.2004.02.004 (Pubitemid 38523333)
41. Fagundes C. T., Amaral F. A., Souza A. L. S., Vieira A. T., Xu D., Liew F. Y., Souza D. G., Teixeira M. M., ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. Journal of Leukocyte Biology 2007 81 2 492 499 2-s2.0-33846698559 10.1189/jlb.0606422 (Pubitemid 46198401)
42. Xu D., Chan W. L., Leung B. P., Huang F., Wheeler R., Piedrafita D., Robinson J. H., Liew F. Y., Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. Journal of Experimental Medicine 1998 187 5 787 794 2-s2.0-2642610290 10.1084/jem.187.5.787 (Pubitemid 28115194)
43. Xu D., Jiang H. R., Kewin P., Li Y., Mu R., Fraser A. R., Pitman N., Kurowska-Stolarska M., McKenzie A. N., McInnes I. B., Liew F. Y., IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences of the United States of America 2008 105 31 10913 10918 10.1073/pnas.0801898105
44. Palmer G., Talabot-Ayer D., Lamacchia C., Toy D., Seemayer C. A., Viatte S., Finckh A., Smith D. E., Gabay C., Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis and Rheumatism 2009 60 3 738 749 2-s2.0-61649117392 10.1002/art.24305
45. Milovanovic M., Volarevic V., Radosavljevic G., Jovanovic I., Pejnovic N., Arsenijevic N., Lukic M. L., IL-33/ST2 axis in inflammation and immunopathology. Immunologic Research 2012 52 1-2 89 99 2-s2.0-84859917147 10.1007/s12026-012-8283-9
46. Humphreys N. E., Xu D., Hepworth M. R., Liew F. Y., Grencis R. K., IL-33, a potent inducer of adaptive immunity to intestinal nematodes. Journal of Immunology 2008 180 4 2443 2449 2-s2.0-42149179961
47. Oboki K., Ohno T., Kajiwara N., Arae K., Morita H., Ishii A., Nambu A., Abe T., Kiyonari H., Matsumoto K., Sudo K., Okumura K., Saito H., Nakae S., IL-33 is a crucial amplifier of innate rather than acquired immunity. Proceedings of the National Academy of Sciences of the United States of America 2010 107 43 18581 18586 2-s2.0-78649821588 10.1073/pnas.1003059107
48. Imaeda H., Andoh A., Aomatsu T., Uchiyama K., Bamba S., Tsujikawa T., Naito Y., Fujiyama Y., Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis. International Journal of Molecular Medicine 2011 28 4 573 578 2-s2.0-79960752111 10.3892/ijmm.2011.718
49. Xu D., Jiang H., Li Y., Pushparaj P. N., Kurowska-Stolarska M., Leung B. P., Mu R., Tay H. K., McKenzie A. N. J., McInnes I. B., Melendez A. J., Liew F. Y., IL-33 exacerbates autoantibody-induced arthritis. Journal of Immunology 2010 184 5 2620 2626 2-s2.0-77951888994 10.4049/jimmunol.0902685
50. Kim S. W., Kim E. S., Moon C. M., Park J. J., Kim T. I., Kim W. H., Cheon J. H., Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease. Gut 2011 60 11 1527 1536 2-s2.0-80053568626 10.1136/gut.2011.238477
51. Andersen V., Ernst A., Christensen J., Østergaard M., Jacobsen B. A., Tjønneland A., Krarup H. B., Vogel U., The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Medical Genetics 2010 11 1, article 82 2-s2.0-77952704894 10.1186/1471-2350-11-82
52. Glas J., Török H., Tonenchi L., Kapser J., Schiemann U., Müller-Myhsok B., Folwaczny M., Folwaczny C., Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype. Inflammatory Bowel Diseases 2005 11 12 1031 1037 2-s2.0-27944432053 10.1097/01.MIB.0000187574.41290.b1 (Pubitemid 41682558)
53. Nemetz A., Nosti-Escanilla M. P., Molnár T., Köpe A., Kovács Á., Fehér J., Tulassay Z., Nagy F., García-González M. A., Peña A. S., IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 1999 49 6 527 531 2-s2.0-0032899896 10.1007/s002510050530 (Pubitemid 29221785)
54. Latiano A., Palmieri O., Pastorelli L., Vecchi M., Pizarro T. T., Bossa F., Merla G., Augello B., Latiano T., Corritore G., Settesoldi A., Valvano M. R., 'Incà R D., Stronati L., Annese V., Andriulli A., Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease. PLoS ONE 2013 8 4 e62144 10.1371/journal.pone.0062144